News

Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...

Lustgarten Foundation alleges $22 million funding in 2017 as part of its mission to invest an unprecedented $40 million by the end of 2018. In a bid to advanced pancreatic Cancer…
Read More...

CGMP contract development and manufacturing organization (CDMO), Nitto Avecia Pharma Services appointed Raymond Kaczmarek as the president entrusting the P&L responsibility for the…
Read More...

U.S Diagnostics confirms distribution of the INFINITY Blood Glucose Monitoring System across Western Africa. Located in New York, INFINITY Blood Glucose Monitoring System…
Read More...

Diplomat Pharmacy mets out CABOMETYX treatment for Renal cell carcinoma inflicted on patients as approved by the Food and Drug administration. Formerly approved as a second-line therapy…
Read More...

BD (Becton, Dickinson and Company), global medical technology company, along with Check-Points Health B.V., affirmed that the companies sought CE Mark for a next-generation molecular…
Read More...

Labeling and detection solutions, Bio-Techne now provides reagents and kits from Vector Laboratories that doles out reliable, sensitive, and low background detection. In October, 2017,…
Read More...

Genomic and Medical research knowledge base powered by the blockchain and owned by its community, Luna DNA declared Dawn Barry as president. Barry will be held accountable for leading…
Read More...

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

U.S FDA approves Teva Pharmaceutical's TRISENOX i.e. Arsenic trioxide injection amalgamated with  tretinoin  in the therapy of adults diagnosed with low -risk acute promyelocytic…
Read More...

Biopharmaceutical Company, Amcure insisted on extending its team of members by further appointing  Heinz Dieter Schwer, PhD, MBA, CEO of ViraTherapeutics. Klaus Dembowsky, MD, PhD,…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Ipsen declared the appointment of Richard Paulson as Executive Vice-president and Chief Executive Officer of Ipsen North America accountable for  commercial operations throughout the…
Read More...

Concert Pharmaceuticals asserted that the U.S FDA has offered Fast Track designation for CTP-543, inhibitor for treatment of moderate-to severe Alopecia Areata discerned as a serious…
Read More...

Fresenius Kabi confirmed the availability of Bortezomib for injection  in the United States. Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 3.5 mg…
Read More...

GSK asserted that it has received approval from the US FDA center for biologics Evaluation and Research thereby hinting at the usage of FLUARIX QUADRIVALENT in persons 6 months and…
Read More...

FDA approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of  Breast Cancer that have become widespread and whose tumors possess inherited…
Read More...